MERTK
Tyrosine-protein kinase Mer
Also known as: c-Eyk, mer, MERTK_HUMAN, RP38, Tyro12
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q12866
- Gene
- MERTK
- Ensembl
- ENSG00000153208
- Chromosome
- 2
- Canonical length
- 999 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Plasma membrane,Midbody,Cytosol,Acrosome,Mid piece,Principal piece
OverviewNCBI Gene
This gene is a member of the MER/AXL/TYRO3 receptor kinase family and encodes a transmembrane protein with two fibronectin type-III domains, two Ig-like C2-type (immunoglobulin-like) domains, and one tyrosine kinase domain. Mutations in this gene have been associated with disruption of the retinal pigment epithelium (RPE) phagocytosis pathway and onset of autosomal recessive retinitis pigmentosa (RP). [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
999 residues, UniProt reviewed canonical sequence.
>Q12866|MERTK
1 MGPAPLPLLL GLFLPALWRR AITEAREEAK PYPLFPGPFP GSLQTDHTPL LSLPHASGYQ
61 PALMFSPTQP GRPHTGNVAI PQVTSVESKP LPPLAFKHTV GHIILSEHKG VKFNCSISVP
121 NIYQDTTISW WKDGKELLGA HHAITQFYPD DEVTAIIASF SITSVQRSDN GSYICKMKIN
181 NEEIVSDPIY IEVQGLPHFT KQPESMNVTR NTAFNLTCQA VGPPEPVNIF WVQNSSRVNE
241 QPEKSPSVLT VPGLTEMAVF SCEAHNDKGL TVSKGVQINI KAIPSPPTEV SIRNSTAHSI
301 LISWVPGFDG YSPFRNCSIQ VKEADPLSNG SVMIFNTSAL PHLYQIKQLQ ALANYSIGVS
361 CMNEIGWSAV SPWILASTTE GAPSVAPLNV TVFLNESSDN VDIRWMKPPT KQQDGELVGY
421 RISHVWQSAG ISKELLEEVG QNGSRARISV QVHNATCTVR IAAVTRGGVG PFSDPVKIFI
481 PAHGWVDYAP SSTPAPGNAD PVLIIFGCFC GFILIGLILY ISLAIRKRVQ ETKFGNAFTE
541 EDSELVVNYI AKKSFCRRAI ELTLHSLGVS EELQNKLEDV VIDRNLLILG KILGEGEFGS
601 VMEGNLKQED GTSLKVAVKT MKLDNSSQRE IEEFLSEAAC MKDFSHPNVI RLLGVCIEMS
661 SQGIPKPMVI LPFMKYGDLH TYLLYSRLET GPKHIPLQTL LKFMVDIALG MEYLSNRNFL
721 HRDLAARNCM LRDDMTVCVA DFGLSKKIYS GDYYRQGRIA KMPVKWIAIE SLADRVYTSK
781 SDVWAFGVTM WEIATRGMTP YPGVQNHEMY DYLLHGHRLK QPEDCLDELY EIMYSCWRTD
841 PLDRPTFSVL RLQLEKLLES LPDVRNQADV IYVNTQLLES SEGLAQGSTL APLDLNIDPD
901 SIIASCTPRA AISVVTAEVH DSKPHEGRYI LNGGSEEWED LTSAPSAAVT AEKNSVLPGE
961 RLVRNGVSWS HSSMLPLGSS LPDELLFADD SSEGSEVLMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MERTK can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 90 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 90 nTPM
- adrenal gland: 56 nTPM
- blood vessel: 31 nTPM
- spleen: 29 nTPM
- epididymis: 25 nTPM
- parathyroid gland: 20 nTPM
Single-cell type
- kupffer cells: 733 nCPM
- macrophages: 428 nCPM
- microglia: 379 nCPM
- pituicytes/fscs: 248 nCPM
- adrenal cortex cells: 246 nCPM
- astrocytes: 224 nCPM
Immune cell
- intermediate monocyte: 8.7 nTPM
- non-classical monocyte: 5.5 nTPM
- classical monocyte: 0.6 nTPM
- total PBMC: 0.2 nTPM
- myeloid DC: 0.1 nTPM
- neutrophil: 0.1 nTPM
Brain region
- choroid plexus: 72 nTPM
- thalamus: 41 nTPM
- basal ganglia: 37 nTPM
- cerebral cortex: 37 nTPM
- medulla oblongata: 28 nTPM
- amygdala: 27 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MERTK.
Disease | AllUniProt
Conditions MERTK is implicated in, by any mechanism.
- Retinitis pigmentosa 38 (RP38) MIM:613862
Disease | GeneticClinVar
128 pathogenic / likely-pathogenic of 903 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Retinitis pigmentosa 38
- Retinal dystrophy
- Retinitis pigmentosa
- Autosomal recessive retinitis pigmentosa
- MERTK-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.75
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.59
- DepMap mean gene effect
- -0.11
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell migration
- cell surface receptor protein tyrosine kinase signaling pathway
- cell surface receptor signaling pathway
- cell-cell signaling
- establishment of localization in cell
- natural killer cell differentiation
- negative regulation of cytokine production
- negative regulation of leukocyte apoptotic process
- negative regulation of lymphocyte activation
- nervous system development
- neutrophil clearance
- phagocytosis
- platelet activation
- positive regulation of phagocytosis
- positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- protein phosphorylation
- retina development in camera-type eye
- secretion by cell
- spermatogenesis
- substrate adhesion-dependent cell spreading
- vagina development
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Protein kinase domain
- Serine-threonine/tyrosine-protein kinase, catalytic domain
- Immunoglobulin domain subtype
- Fibronectin type III
- Immunoglobulin-like domain
- Tyrosine-protein kinase, active site
- Protein kinase-like domain superfamily
- Immunoglobulin-like beta-sandwich domain
- Immunoglobulin-like fold
- Protein kinase, ATP binding site
- Tyrosine-protein kinase, catalytic domain
- Fibronectin type III superfamily
- Immunoglobulin-like domain superfamily
- Receptor Tyrosine Kinase
- Fibronectin type III domain
- Immunoglobulin domain
- Protein tyrosine and serine/threonine kinase
- Immunoglobulin domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MERTK in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MERTK as an antibody target. Whether an autoantibody or antibody against MERTK could matter depends on whether native MERTK is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MERTK is annotated at the cell surface, where native MERTK is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label MERTK as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...